DXCM

Healthcare Medical Devices

DexCom, Inc.

$85.36

-0.32 -0.37% today

Price History

Not enough data

Key Stats

Market Cap

32.21B

Avg Volume

4.53M

P/E (TTM)

33.74

EPS

$2.53

52W High

$92.59

52W Low

$54.11

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

27.34

P/B Ratio

12.29

P/S Ratio

6.48

EV/EBITDA

22.57

EV/Revenue

6.37

PEG Ratio

1.31

Margins

Gross Margin 62.5%

Operating Margin 24.3%

Net Margin 20.1%

EBITDA Margin 28.2%

Growth & Returns

Revenue Growth (YoY)

13.1%

Earnings Growth (YoY)

43.6%

Earnings Growth (QoQ)

38.5%

Return on Equity

38.5%

Return on Assets

10.3%

Liquidity & Leverage

Current Ratio

1.73

Quick Ratio

1.37

Debt / Equity

0.53

Total Cash

1.95B

Total Debt

1.40B

About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.